You must be logged in to view this content
This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.
Description
Intraocular open-capsule device (IOCD), for posterior capsule opacification (PCO) prevention, of different designs investigate in three rabbit studies, in comparison to a control group that implanted with the same IOL but without the IOCD. The eyes evaluated for PCO and Soemmering’s ring clinically, by the Miyake Apple view and histologically. All the devices showed significant prevention of about 80% of PCO and Soemmering’s ring compared with the control group.
Intraocular open-capsule device (IOCD), for posterior capsule opacification (PCO) prevention, of different designs investigate in three rabbit studies, in comparison to a control group that implanted with the same IOL but without the IOCD. The eyes evaluated for PCO and Soemmering’s ring clinically, by the Miyake Apple view and histologically. All the devices showed significant prevention of about 80% of PCO and Soemmering’s ring compared with the control group.
View More Films
This film was submitted to the 37th Annual ASCRS Film Festival within the 2019 ASCRS ASOA Annual Meeting.